We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dusa, River's Edge Settle Acne Drug Patent Dispute

Law360 (October 29, 2007, 12:00 AM EDT) -- River's Edge LLC has agreed to permanently cease making and selling a generic version of Dusa Pharmaceuticals Inc.'s acne treatment Nicomide as part of a settlement that will put to rest a patent infringement lawsuit brought against River's Edge in April 2006.

In addition to stopping the manufacture and sale of its nicotinamide product NIC 750, River's Edge will make a lump-sum payment to Dusa, and concede that Dusa's patent is valid and enforceable, Dusa said Monday.

River's Edge will also stop participating in the re-examination...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.